Results 291 to 300 of about 3,485,250 (372)

Institutional repository trends

, 2007
Peter Suber
openalex   +1 more source

UPC institutional repositories

, 2007
Casadevall, Marina, Hidalgo, Montse, Rovira, Anna   +2 more
openaire   +1 more source

Video education in open trauma: a program for developing trauma surgical skills. [PDF]

BMC Med Educ
Ramos JP, Zinco A, Bryan MR, Bensen GP, Alty IG, Roy N, Raykar N, Ottolino P.   +7 more
europepmc   +1 more source

Bibliography on filling institutional repositories

, 2007
Peter Suber
openalex   +1 more source

ML@ChemE: Past, Present, and Future of Machine Learning in Chemical Engineering

ChemBioEng Reviews, EarlyView.
Although the initial machine learning (ML) applications were mainly on fault detection, signal processing, and process modeling, they extended to new areas like property estimation and material screening in later years; energy technologies, environmental issues, health, and new materials will likely be more important in future with the use of larger ...
Pınar Özdemir, Ramazan Yıldırım
wiley   +1 more source

Consistently processed RNA sequencing data from 50 sources enriched for pediatric data. [PDF]

Sci Data
Beale HC, Learned K, Kephart ET, Lyle AG, van den Bout A, McCabe M, Echandia-Monroe K, Khare MJ, Huang EY, Jariwala S, Antilla R, Cheney A, Lee AG, Sayles LC, Leung SG, Vasquez YA, Sanders L, Haussler D, Salama SR, Sweet-Cordero EA, Vaske OM.   +20 more
europepmc   +1 more source

JISC support for institutional repositories

, 2007
Peter Suber
openalex   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

Long-Term miRNA Changes Predicting Resiliency Factors of Post-Traumatic Stress Disorder in a Large Military Cohort-Millennium Cohort Study. [PDF]

Int J Mol Sci
Yang R, Kannan S, Gautam A, Powell TM, LeardMann CA, Hoke AV, Dimitrov GI, Jett M, Donoho CJ, Rull RP, Hammamieh R.   +10 more
europepmc   +1 more source

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies

Clinical Pharmacology &Therapeutics, EarlyView.
The potential of real‐world data (RWD), particularly from patient registries, has been increasingly recognized over the last decade by academia, regulators, and health technology assessment (HTA) bodies for its role in assessing a product's effectiveness and supporting regulatory submissions.
Sonia Zebachi, Julien Tanniou, Elisabeth Bakker, Sieta T. de Vries, Rossella Di Bidino, Entela Xoxi, Anna Glaser, Gianluigi Savarese, Jan Hillert, Peter G. M. Mol, Kelly Plueschke, Billy Amzal, Ghinwa Y. Hayek, Jeverson Moreira   +13 more
wiley   +1 more source